BiotechTube

norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Female Contraception

Conditions

Female Contraception

Trial Timeline

May 1, 2004 โ†’ Aug 1, 2004

NCT ID
NCT00775086

About norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.

norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system. is a phase 1 stage product being developed by Johnson & Johnson for Female Contraception. The current trial status is completed. This product is registered under clinical trial identifier NCT00775086. Target conditions include Female Contraception.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00775086Phase 1Completed

Competing Products

20 competing products in Female Contraception

See all competitors
ProductCompanyStageHype Score
Fulvestrant + AbemaciclibEli LillyPhase 2
52
Gemcitabine + liposomal doxorubicinEli LillyPhase 3
77
ASP3325 + PlaceboAstellas PharmaPhase 1
33
EnsitrelvirShionogiPhase 1
33
Eribulin Injection [Halaven] + Paclitaxel injectionEisaiApproved
85
Gemcitabine + Paclitaxel + CarboplatinEli LillyPhase 3
77
Abemaciclib 50 MG; 150mg 1-0-1 per osEli LillyPhase 3
77
Abemaciclib, durvalumab and aromatase inhibitorEli LillyPhase 1
33
Norgestimate/Ehinyl Estradiol; Folic acid.Johnson & JohnsonPhase 1
33
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR7280 tabletsJiangsu Hengrui MedicinePhase 2
52
SHR7280๏ผ›Ganirelix Acetate Injection simulant + SHR7280 simulant๏ผ› Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
77
SHR3162Jiangsu Hengrui MedicinePhase 1
33
AZD3293 + PlaceboAstraZenecaPhase 1
33
Fulvestrant 500mg + Palbociclib 125mg + Goserelin 3.6 MG + PlacebosAstraZenecaPhase 3
77
AZD2516 + PlaceboAstraZenecaPhase 1
33
Durvalumab + TremelimumabAstraZenecaPhase 2
52
Dapagliflozin + Metformin + Dapagliflozin + MetforminAstraZenecaPhase 1
33
AZD4901 (oral) + Placebo to match AZD4901AstraZenecaPhase 2
52
Zibotentan + EE/LNGAstraZenecaPhase 1
33

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85